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Copy number variation of human AMY1 is a
minor contributor to variation in salivary
amylase expression and activity
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Abstract
Background: Salivary amylase in humans is encoded by the copy variable gene AMY1 in the amylase gene cluster
on chromosome 1. Although the role of salivary amylase is well established, the consequences of the copy number
variation (CNV) at AMY1 on salivary amylase protein production are less well understood. The amylase gene cluster
is highly structured with a fundamental difference between odd and even AMY1 copy number haplotypes. In this
study, we aimed to explore, in samples from 119 unrelated individuals, not only the effects of AMY1 CNV on salivary
amylase protein expression and amylase enzyme activity but also whether there is any evidence for underlying
difference between the common haplotypes containing odd numbers of AMY1 and even copy number haplotypes.
Results: AMY1 copy number was significantly correlated with the variation observed in salivary amylase production
(11.7% of variance, P < 0.0005) and enzyme activity (13.6% of variance, P < 0.0005) but did not explain the majority
of observed variation between individuals. AMY1-odd and AMY1-even haplotypes showed a different relationship
between copy number and expression levels, but the difference was not statistically significant (P = 0.052).
Conclusions: Production of salivary amylase is correlated with AMY1 CNV, but the majority of interindividual
variation comes from other sources. Long-range haplotype structure may affect expression, but this was not
significant in our data.
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Introduction
The enzyme amylase plays a major role in starch hydroly-
sis, which begins in the oral cavity and continues into the
stomach and then small intestine. Amylase is the most
abundant protein in saliva, accounting for at least 50% of
salivary protein [1], but the quantity and enzyme activity
of salivary amylase varies greatly among individuals. This
variation in amylase production could be attributable to a
number of factors including environmental factors, such
as stress [2] and circadian rhythms [3], oral health [4] and
the genetic background of an individual’s amylase gene
cluster. Whilst it has been suggested that quantitative vari-
ation in amylase protein patterns does not always reflect
variation in the amylase gene cluster [5], some studies
have shown a relationship between the observed copy
number variation (CNV) at the salivary amylase gene
(AMY1) and an increased level of amylase protein expres-
sion [6, 7]. Perry et al. [7], using immunoblotting to inves-
tigate amylase protein levels, identified a significant
positive correlation (R = 0.59) between CNV at AMY1 and
levels of amylase protein in saliva. Mandel and colleagues
[6], also using immunoblotting, observed a similar correl-
ation (R = 0.50) with copy number at AMY1 and amylase
protein levels as well as a correlation (R = 0.52) between
CNV at AMY1 and salivary enzyme activity. These results
suggest that approximately 20–35% of the variance in
salivary amylase expression can be attributed to variation
in AMY1 copy number.
The human amylase genes form a cluster on chromo-
some 1 which contains both the salivary (AMY1) and
pancreatic (AMY2) amylase genes, both of which vary in
copy number [5, 8, 9]. The CNV at AMY1 has an observed
range of 2–18 copies per person [7, 10–12] and an average
of 6 copies per person, whilst the CNV at AMY2 has an
observed range of 2–12 copies per person and an average
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of 4 copies per person. The amylase gene cluster is highly
structured [13–15], with a correlation between the CNV at
AMY1 and the CNV at AMY2 [10, 12]. Recent observa-
tions have identified a fundamental difference in the under-
lying genomic structure across the amylase gene cluster
between majority haplotypes containing an odd number of
copies of AMY1 and one copy each of AMY2A and
AMY2B, and less common variant haplotypes containing
even copy number haplotypes of AMY1 and deletions or
duplications of AMY2 genes. Consequently, the majority of
individuals (60–70%), with two AMY1-odd haplotypes,
have an even copy number of AMY1 and no CNV of
AMY2, whereas those individuals with an odd copy num-
ber of AMY1 (usually heterozygous for an AMY1-even
haplotype) also display CNV of AMY2 [10, 12].
Previous studies investigating the relationship be-
tween CNV at AMY1 and salivary amylase protein
expression have used qPCR to measure copy number.
However, qPCR measurement of AMY1 has since been
shown to be subject to systematic error and, in one
study, consistently underestimated the AMY1 copy
number [7, 10]. We aimed to re-evaluate the relation-
ship between CNV at AMY1 and salivary amylase
protein expression using alternative copy number
measurement methods that have been shown to be
precise and reproducible [10]. Our experimental plan
was designed to measure both the expression of salivary
amylase total protein and amylase enzyme activity in
saliva from a larger cohort of individuals than has been
previously studied, in parallel with determination of
copy number at AMY1. Knowledge of the haplotype
structures also allows us to test whether all copies of
AMY1 are functionally equivalent or whether there is
any evidence for context dependence of gene expres-
sion. Therefore, our aim is to explore the functional
consequences of the multi-allelic copy variable gene
AMY1 on more (N = 119) samples than previously
investigated and using novel methods of AMY1 copy
number measurement, capable of resolving single inte-
ger copy numbers.
Results
Variation in AMY1 and AMY2 copy numbers
Copy number measurement of both AMY1 and AMY2
was performed on all 119 independent UK samples (see
“Methods”). The AMY1 copy number distribution is
shown in Fig. 1 and shows a predominance of even copy
numbers (75%), with a range of 2–15 and a modal copy
number of 6, consistent with prior studies of AMY1 copy
number [7, 10–12]. Variation in AMY2 copy number
was also observed with AMY2A copy variable in 24% of
samples and AMY2B showing CNV in about 10% of
samples (Table 1).
Correlation of AMY1 copy number with protein
production and enzyme activity
We investigated both amylase protein levels and salivary
amylase enzyme activity. Our data are consistent with
previous studies in exhibiting considerable variation in
protein expression [6, 7] and include some samples
(across all copy numbers) with very low amounts of
amylase protein (lowest value 0.48 mg/mL), as also de-
tected by Mandel et al. [6].
The raw data for total protein (antigen) concentra-
tion (Fig. 2) and for enzyme activity (Fig. 3) did not
show a strong relationship with copy number, and the
residuals of the regression are far from normally
distributed (Additional file 1: Figure S2). A linear re-
gression was performed using log10 of protein and of
enzyme activity giving residuals that follow a normal
distribution (Additional file 1: Figure S2) and satisfy
other assumptions of linear regression modelling, and
therefore, all further analyses were performed with
the transformed data.
Fig. 1 Distribution histogram of AMY1 copy number in 119
unrelated UK samples; a clear majority have even copy numbers (89
out of 119)
Table 1 CNV of AMY2 in 119 UK samples studied
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A significant correlation was observed between AMY1
copy number and amylase protein (R = 0.342) (P < 0.0005).
Our data suggests that AMY1 copy number accounts for
11.7% of the variation observed in salivary amylase protein
levels, much less than previous reports of 35% from a
study of 50 European American individuals [7], and 25%
in a study of 62 individuals of unspecified ancestry [6].
Our observation suggests that the CNV at AMY1 plays
much less of a role in the variation of salivary amylase
protein levels than previously proposed. Furthermore, the
great spread of observed levels of amylase protein
production suggests that the genetic contribution of the
CNV is not simply proportional to protein production.
A similar relationship was observed with salivary amylase
enzyme activity. A significant correlation was observed be-
tween AMY1 copy number and enzyme activity (R = 0.369)
(P < 0.0005). Again, our data suggest that copy number
plays less of a role than previously reported, with copy
number accounting for 13.6% of the variation in enzyme
activity observed in our study, rather than 27% as previ-
ously suggested [6]. A similar observation was reported in a
Chinese population (n = 92) which found the gene copy
number provided 12.2% of the observed salivary enzyme
activity variation [16]. However, direct comparison between
these studies is not straightforward, as Chinese populations
do have a distinct AMY1 distribution to Europeans [10, 12].
As our copy number measurement system is accurate
enough to assign single integers, we were able to investi-
gate whether there are differences in gene expression
between those individuals that have even AMY1 copy
numbers and those with odd. We fitted a logistic regres-
sion model to protein and copy number data and used the
model to predict protein expression from copy number to
examine whether the odd or even number status was
associated with a systematic difference in the relationship.
This analysis gave marginally non-significant evidence
(P= 0.052) for a difference between the regressions of log
protein with even (R = 0.168) and odd (R = 0.017) copy
numbers (Additional file 1: Figure S3), suggesting that the
relationship between copy number and protein may be
different for the odd and even copy numbers.
Discussion
This is only the second study to investigate both protein
levels and enzyme activity in the same samples. There is
a highly significant correlation between the two mea-
sures (R = 0.66; P < 0.0001) (Additional file 1: Figure S4);
whilst this is not a strong relationship, it is consistent
with previous observations between these two measures
(R = 0.61) [6]. This observation does suggest that for a
particular quantity of amylase protein, there are varia-
tions in measurable enzyme activity, and supports the
proposal that the enzymatic functions of amylase may be
affected by protein modifications or the formation of
complexes [6, 17].
With the complex underlying structure at the amylase
gene cluster, it is possible that longer-range structure, in-
cluding the CNV at AMY2, may influence AMY1 expres-
sion, but there was no significant correlation observed
between CNV at either AMY2A or AMY2B with either
salivary amylase protein production or enzyme activity.
Conclusions
To re-assess the relationship between copy number and
salivary amylase protein expression and activity, our
Fig. 2 A box and whiskers plot of amylase protein concentration by
AMY1 copy number, with mean for all samples at a given copy
number shown as a black bar, the standard deviation as the box,
and whiskers showing the observed full range of data. Each
contributing data point is the mean of three experimental replicates,
and further details of biological replicates from the same subjects
can be found in the “Methods”
Fig. 3 A box and whiskers plot of amylase enzyme activity by AMY1
copy number, with mean of all samples at each copy number
shown as a black bar, and whiskers showing the observed range of
data. The boxes indicate the standard deviation at each copy
number. Each data point used in the analysis is the mean of two
experimental replicates, and further details of biological replicates
from the same subjects can be found in the “Methods”
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work used a more accurate and precise AMY1 copy
number measurement method than the qPCR methods
previously employed. Our previous work demonstrated
the reliability of PRT-based methods and the susceptibil-
ity of qPCR methods to measurement error [10]. Our
data clearly show that copy number plays much less of a
role in salivary amylase expression and activity than has
been previously suggested, and that it is not possible to
predict an individual’s salivary amylase concentration or
enzyme activity solely from their copy number, with
implications for studies of the effects of AMY1 copy
number variation, such as with diet. It is interesting to
speculate on possible reasons for the differences between
our results and those of other researchers. In addition to
the improved methodology for copy number measure-
ment, there may also have been differences in the
sampling regime for saliva; in our work, we specified the
method and time of collection but did not examine or
standardise other factors, such as the timing relative to
meals. Because of the fundamental structural difference
between haplotypes containing odd or even numbers of
copies, we wanted to test the possibility that odd or even
number haplotypes might have different relationships
between copy number and gene expression. Our data
neither confirm nor exclude functional differences that
arise from the underlying genomic structure across the
amylase region between odd and even copy number
haplotypes. Further studies would be needed to support
the idea, but it does remain possible that the longer-
range genomic structure, in addition to AMY1 copy




Our analysis utilised 120 independent volunteers from
the University of Nottingham staff and student body,
with 10 randomly selected to provide repeat samples.
The blood, for DNA extraction, and saliva, for salivary
amylase analysis, were taken with full consent from indi-
viduals and under local ethical approval (University of
Nottingham Medical School Ethics Committee approval
reference number BT10/02/2010). All samples were of
the UK origin with no known clinical phenotype. DNA
was extracted using isolated lymphocytes and a standard
‘salting out’ method for protein removal followed by
phenol-chloroform extraction. DNA concentration was
measured using a NanoDrop spectrophotometer, and
DNA purity was assessed from the 260:280 nm absorb-
ance ratio. All samples were diluted to a working
concentration of 10 ng/mL. DNA was successfully ex-
tracted for all samples, except one, giving a total sample
size of 119 independent individuals.
Sample preparation
The saliva samples were collected from each volunteer
at approximately 9.30 am (+/−10 min). The volunteers
chewed on a 4 cm piece of parafilm for 30 s to allow
saliva to be produced and then collected into a 15 ml
sterile polypropylene container. The tubes were centri-
fuged at 13 rpm for 5 min to remove any solids from the
suspension, and the remaining saliva was stored at −80 °
C. For genotyping, 20 mL of the whole blood was taken
from each volunteer from which genomic DNA was
isolated and stored at −80 °C.
Measurement of AMY1 and AMY2 copy numbers
The copy number of AMY1 was measured from genomic
DNA using a paralogue ratio test (PRT) in combination
with a TATC microsatellite assay, as previously described
[10]. AMY2 copy number was measured using an
AMY2A:AMY2B ratio assay, an AMY2A:AMY2A pseudo-
gene ratio assay and an AMY2A/2B duplication junction
assay, as previously described [10].
PRT PCR reactions were performed using previously
described primers PRT_ref12 [10] that amplify from
each copy of AMY1 and from a reference locus at
hg19 chr12:9,867,565–9,867,813. PCR products were
mixed with 10 μl HiDi formamide with ROX-500
marker (Applied Biosystems, Warrington, UK), and
subsequent fragment analysis was carried out by elec-
trophoresis on an ABI3130xl 36 cm capillary using
POP-7 polymer with an injection time of 30 s at
1 kV. GeneMapper software (Applied Biosystems,
Warrington, UK) was used to extract the peak areas
for the PRT and calculate the ratio of test (244 bp) to refer-
ence (249 bp) products. Copy number values were calcu-
lated by calibrating the ratios using HapMap CEU samples
[NA11930 with AMY1 copy number (CN) = 2; NA06993
with CN= 6; NA10852 with CN = 6; NA10835 with CN =
8; NA12248 with CN= 8; NA11931 with CN= 8; NA11993
with CN = 10 and NA07347 with CN= 11], which were in-
cluded in every experiment in duplicate.
For further confirmation of AMY1 gene copy number,
a TATC microsatellite PCR was performed for each
sample [10]. A single PCR reaction was performed and
the products were mixed with 10 μl HiDi formamide
with ROX-500 marker (Applied Biosystems, Warrington,
UK), and fragment analysis was carried out by electro-
phoresis on an ABI3130xl 36 cm capillary using POP-7
polymer with an injection time of 30 s at 1 kV. Gene-
Mapper software (Applied Biosystems, Warrington, UK)
was used to extract the peak areas.
The ratio of AMY2A copy number to AMY2B copy
number and the ratio of AMY2A copy number to
AMY2A pseudogene copy number were measured as
previously described [10]. One microliter of PCR prod-
ucts from both assays were mixed and added to 10 μl
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HiDi formamide with ROX-500 marker (Applied Biosys-
tems, Warrington, UK), and fragment analysis was carried
out by electrophoresis on an ABI3130xl 36 cm capillary
using POP-7 polymer, injecting at 1 kV for 10 s. Gene-
Mapper software (Applied Biosystems, Warrington, UK)
was used to extract the peak areas and calculate the ratio
of AMY2A (163 bp) to AMY2B (167 bp) and the ratio of
AMY2A (197 bp) to AMY2A pseudogene (232 bp).
The AMY2A/2B duplication junction assay is a three-
primer assay producing PCR amplicons of 424 bp in all
samples and a specific 323 bp only from the duplication
junction. The products were visualised on a 2% (w/v)
agarose gel, as previously described [10].
Measurement of amylase protein
The concentration of amylase protein antigen present in
the saliva was measured using a sandwich amylase
ELISA with 1 μg/mL of anti-salivary amylase antibody
(Abcam, Cambridge, UK) and 100 μg/mL of biotinylated
detection antibody (Biorbyt, Cambridge, UK). Assays
were performed using serial dilutions (1:5) of natural
human salivary amylase protein of known concentration
(200 μg/mL) (Sigma-Aldrich, Gillingham, Dorset, UK) to
generate a standard curve. Assays were performed in
duplicate for each unknown sample, and the standard
curve was measured in triplicate.
Measurement of amylase enzyme activity
The amylase enzyme activity within saliva was measured
using the EnzCheck® Ultra Amylase Assay Kit (Invitrogen,
ThermoFisher, Paisley, UK) according to manufacturer’s
instructions. The saliva samples were added to the
substrate solution, vortexed, and the fluorescence of the
samples was measured after 10 min incubation at room
temperature. Assays were performed using serial dilutions
(1:5) of natural salivary amylase protein of known concen-
tration (200 μg/mL) (Sigma-Aldrich, Gillingham, Dorset,
UK) to generate a standard curve. Assays were performed
in duplicate for each unknown sample, and the standard
curve was measured in triplicate.
In order to deduce the variation in concentration for
protein expression and enzyme activity within each indi-
vidual, the repeat samples from an initial cohort of 10
individuals were investigated on four separate occasions
(Additional file 1: Figure S1). These 10 repeat samples
comprise samples with 2 (×1), 4 (×1), 6 (×4), 8 (×2) and
9 (×2) copies of AMY1. Analysis of repeat measures
found that neither of the within-subject factors (time
and measurement) was significant for measurement of
salivary amylase protein expression or enzyme activity,
and therefore, a single time point is suitable for compar-
ing measurements of salivary amylase protein and
enzyme activity between individuals.
Bradford assay for measurement of total protein
concentration
The total protein concentration in the saliva samples
was measured using Bradford Reagent (Sigma-Aldrich,
Gillingham, Dorset, UK) according to manufacturer’s in-
structions. Assays were performed using serial dilutions
(1:2) of bovine serum albumin (BSA) protein of known
concentration (1.4 mg/mL) (Sigma-Aldrich, Gillingham,
Dorset, UK) to generate a standard curve. Assays were
performed in duplicate for each unknown sample, and
the standard curve measured in triplicate.
Statistical analysis
Correlations between groups of copy number data and
either protein expression or enzyme activity were
assessed using logistic regression in SPSS V22 (IBM,
Armonk, New York, USA), and figures were drawn with
the software GraphPad Prism (GraphPad Software, Inc.,
La Jolla, CA, USA). The repeat measures were analysed
in SPSS using a general linear model with repeated
measures, with the within-subject factors defined as time
and measurement and the between-subject factor
defined as copy number.
Additional files
Additional file 1: Additional Figures for Carpenter et al., “Copy number
variation of human AMY1 is a minor contributor to variation in salivary
amylase expression and activity”. Figure S1. Graphs for the time trial
samples illustrating the overall variation observed for each sample from
the four separate time points. The samples are sorted by copy number
for amylase protein concentration (A) and enzyme activity (B). Figure S2.
Normal P-P plots of the residuals from logistic regression analysis for (A)
amylase protein concentration, (B) Log10 protein concentration, (C)
amylase enzyme activity and (D) Log10 enzyme activity. Figure S3. Graph
of the residuals from logistic regression between log10 protein
(LogProtein) with odd (blue circles) and even (green circles) AMY1
copy numbers shown separately. Figure S4. Correlation between
salivary amylase protein levels (mg/mL) and amylase enzyme activity
(U/mL). (PDF 425 kb)
Additional file 2: Dataset (XLSX 22 kb)
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